APA (7th ed.) Citation

Abhishek De, Shrayan Pal, Sushil Singh, Disha Chakroborty, & Kiran Godse. (2024). An Open-Label, Investigator-Initiated, Single-Centre Pilot Study to Determine the Safety and Efficacy of Tofacitinib in Resistant Chronic Spontaneous Urticaria. Wolters Kluwer Medknow Publications.

Chicago Style (17th ed.) Citation

Abhishek De, Shrayan Pal, Sushil Singh, Disha Chakroborty, and Kiran Godse. An Open-Label, Investigator-Initiated, Single-Centre Pilot Study to Determine the Safety and Efficacy of Tofacitinib in Resistant Chronic Spontaneous Urticaria. Wolters Kluwer Medknow Publications, 2024.

MLA (9th ed.) Citation

Abhishek De, et al. An Open-Label, Investigator-Initiated, Single-Centre Pilot Study to Determine the Safety and Efficacy of Tofacitinib in Resistant Chronic Spontaneous Urticaria. Wolters Kluwer Medknow Publications, 2024.